Company Monitoring Page for Astellas

latest headlines for company on cafepharma

Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential
Seeking Alpha
Sat, 05/4/13 - 10:32 am
Tags:
Vertex Pharmaceuticals, Pharmacyclics, Novartis, Celsion, Peregrine Pharmaceuticals, Prana, Navidea Biopharmaceuticals, Cardinal Health, ONYX Pharmaceuticals, Bayer, Sarepta, Hyperion Therapeutics, Amarin, Medivation, Astellas, JNJ, Trius, Sangamo BioSciences
Astellas, GSK vie to make 'high altitude' anemia pill
Reuters
Fri, 04/19/13 - 08:52 am
Tags:
Astellas, GSK, anemia, GSK 1278863, FibroGen, FG-4592
GSK’s Contract Manufacturing Delays Cause Shortage of Restless Leg Treatment
Outsourcing Pharma
Thu, 04/18/13 - 08:21 am
Tags:
restless legs syndrome, GSK, CMOs, drug shortages, XenoPort, Astellas, Horizant
Optimer Said to Draw Takeover Interest From Glaxo, Astellas
Bloomberg
Tue, 04/2/13 - 10:04 am
Tags:
GSK, Astellas, M&A, Optimer Pharmaceuticals, AstraZeneca, Cubist Pharmaceuticals
Medivation, Astellas Pharma provide update on Phase 3 PREVAIL
Yahoo/Fly on the Wall
Mon, 04/1/13 - 10:49 am
Tags:
Astellas, Medivation, metastatic castration-resistant prostate cancer, prostate cancer, Xtandi
Tackling Cancer: Lung Cancer's Biggest Current and Upcoming Players
Motley Fool
Wed, 03/20/13 - 11:56 am
Tags:
lung cancer, Roche, Avastin, Tarceva, Astellas, Pfizer, Xalkori, Celgene, Abraxane, Gemzar, Alimta, Eli Lilly
Cubist Pharma buys out antibiotic partner Astellas for $25M-plus
Fierce Biotech
Mon, 03/11/13 - 12:34 pm
Tags:
Cubist Pharma, Astellas, ceftolozane
Tackling Cancer: Prostate Cancer's Biggest Current and Upcoming Players
Motley Fool
Wed, 03/6/13 - 09:49 am
Tags:
prostate cancer, Zytiga, JNJ, Xtandi, Medivation, Astellas, Provenge, Dendreon, Jevtana, Sanofi
Johnson & Johnson's Pioneering Zytiga And Its Competitors
Seeking Alpha
Sun, 02/24/13 - 02:24 pm
Tags:
Zytiga. ARN-509, Xtandi, prostate cancer, Medivation, JNJ, Astellas, Aragon, Tokai
Which Biotech Company Will Be Bought Out Next?
Motley Fool
Sun, 01/27/13 - 11:18 am
Tags:
Theravance, GSK, Astellas, Vivus, Eli Lilly, Immunogen, Roche, M&A
FDA fast tracks two new lung cancer drugs
PM Live
Fri, 01/18/13 - 10:17 am
Tags:
fast track, FDA, Boehringer Ingelheim, Astellas, Roche, Afatinib, Tarceva, non-small cell lung cancer
Zytiga, Xtandi will help pump prostate cancer market to $9.1B
Fierce Pharma
Tue, 11/13/12 - 05:45 pm
Tags:
Xtandi, Zytiga, prostate cancer, JNJ, Medivation, Astellas
Medivation Prostate Cancer Drug Launches Hot
TheStreet.com
Thu, 11/1/12 - 11:50 am
Tags:
Medivation, prostate cancer, Astellas, Xtandi
Astellas launches bladder drug, aiming for a $1.9B franchise
Fierce Pharma
Mon, 10/22/12 - 12:11 pm
Tags:
Astellas, Myrbetriq, overactive bladder
J&J and Astellas Collaborate
Yahoo/Zacks
Thu, 10/4/12 - 10:42 am
Tags:
JNJ, Astellas, JAK inhibitors, ASP015K, rheumatoid arthritis
Medivation and Astellas Announce New Data From XTANDI(R) (enzalutamide) Pivotal Study
Yahoo/MarketWire
Sun, 09/30/12 - 10:34 am
Tags:
Astellas, Medivation, Enzalutamide, prostate cancer
Abbott inks pact with Astellas Pharma in Phase 3 clinical trial for ASP0113
Healthcare Global
Sat, 09/8/12 - 11:33 am
Tags:
Abbott, Astellas, ASP0113, cytomegalovirus, vaccines
Abbott to Collaborate with Astellas in CMV Vaccine Trial
Yahoo
Thu, 09/6/12 - 10:19 am
Tags:
Abbott Labs, Astellas, vaccines, CMV
This Drug Is Getting Some Negative ATTENTION: ArQule's Tivantinib
Motley Fool
Fri, 08/31/12 - 12:27 pm
Tags:
tivantinib, Arqule, lung cancer, Tarceva, Roche, Astellas
Decision Date for Medivation Drug
Yahoo/Zacks
Tue, 08/7/12 - 05:53 pm
Tags:
Medivation, Astellas, Enzalutamide, prostate cancer

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.